This inventor holds 1 USPTO granted patent. Top assignee: Dongguk University Industry-Academic Cooperation Foundation. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Innovations of Ji Yun Ko in Stem Cell Technology
Introduction
Ji Yun Ko is a prominent inventor based in Goyang-si, South Korea. She has made significant contributions to the field of stem cell technology, particularly through her innovative patent related to gene therapy. Her work focuses on developing non-viral vectors that enhance the efficiency of stem cell differentiation.
Latest Patents
Ji Yun Ko holds a patent for a non-viral minicircle vector carrying the SOX gene and its construction method. This invention relates to a non-viral minicircle vector that expresses the SOX gene, which is crucial for stem cell differentiation. The technology allows for the transformation of mesenchymal stem cells without the need for expensive growth factors, simplifying the process of inducing differentiation into chondrocytes. The vector minimizes the transfer of unnecessary genes, making it a promising tool for clinical applications in stem cell-gene therapy.
Career Highlights
Ji Yun Ko is affiliated with the Dongguk University Industry-Academic Cooperation Foundation. Her research has focused on advancing stem cell therapies and improving the methods used in regenerative medicine. She has demonstrated a commitment to innovation in her field, contributing to the development of more efficient and cost-effective solutions.
Collaborations
Ji Yun Ko has collaborated with notable colleagues, including Gun Il Im and Jong Min Lee. These partnerships have furthered her research and expanded the impact of her inventions in the scientific community.
Conclusion
Ji Yun Ko's work exemplifies the intersection of innovation and practical application in stem cell technology. Her contributions are paving the way for advancements in regenerative medicine and gene therapy.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile